Is BRCA2 c.67+62T>G pathogenic?

BRCA2 c.67+62T>G is classified Benign/Likely benign in BRCA2 (ClinVar, Multiple submitters, 11 submitters; last evaluated 2026-06-01). Low-frequency (popmax 2.3%, mid); Associated with hereditary neoplastic syndrome.

What condition is associated with BRCA2 c.67+62T>G?

BRCA2 c.67+62T>G is associated with hereditary neoplastic syndrome, hereditary breast ovarian cancer syndrome, breast-ovarian cancer, familial, susceptibility to, 2 (ClinVar).

How common is BRCA2 c.67+62T>G in the general population?

BRCA2 c.67+62T>G is low-frequency (popmax 2.3%, mid) (gnomAD).

BRCA2 c.67+62T>G

rs11571574 · VCV125991

Benign/Likely benign Multiple submitters

Classification

Benign/Likely benign

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 11 submitters

gnomAD v4.1

Rare

low-frequency (popmax 2.3%, mid)

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
Splice region	donor +62	deep intronic (+62 nt into the intron)
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 3.7	GERP -3.3, phastCons 0.99
Overall
CADD	14.99	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 2.3% Middle Eastern · 111/4,830 alleles

Filtering AF 1.95% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.82%

Overall 0.262% 3,854/1,469,116 alleles · low-frequency

Ancestry group	Frequency	1 in
Middle Easterngrpmax	2.3%	44
Ashkenazi Jewishnot grpmax-eligible	0.759%	132
South Asian	0.457%	219
Admixed American	0.437%	229
Remaining individualsnot grpmax-eligible	0.432%	231
Finnishnot grpmax-eligible	0.27%	370
African / African-American	0.245%	407
European (non-Finnish)	0.217%	460

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: BRCA2
Coding: c.67+62T>G
MANE Select: NM_000059
dbSNP: rs11571574
Type: single nucleotide variant
Location: chr13:32316589 (GRCh38)
Gene constraint: LOEUF 0.803 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)

Full BRCA2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: hereditary breast ovarian cancer syndrome breast-ovarian cancer, familial, susceptibility to, 2

Similar variants

BRCA2 c.316+1G>T Pathogenic ★★★ same condition
BRCA2 c.316+2T>C Pathogenic ★★★ same condition
BRCA2 c.316+5G>A Pathogenic ★★★ same condition
BRCA2 c.316+5G>C Pathogenic ★★★ same condition
BRCA2 c.475+1G>A Pathogenic ★★★ same condition
BRCA2 c.475+1G>T Pathogenic ★★★ same condition
BRCA2 c.476-2A>G Pathogenic ★★★ same condition
BRCA2 c.517-2A>G Pathogenic ★★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/brca2-c-67-plus-62t-g (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown